Lucira Health, Inc. (LHDX): Price and Financial Metrics


Lucira Health, Inc. (LHDX): $1.86

0.14 (+8.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

LHDX Stock Price Chart Interactive Chart >

Price chart for LHDX

LHDX Price/Volume Stats

Current price $1.86 52-week high $11.10
Prev. close $1.72 52-week low $1.36
Day low $1.69 Volume 41,500
Day high $1.86 Avg. volume 116,173
50-day MA $2.18 Dividend yield N/A
200-day MA $4.77 Market Cap 74.15M

Lucira Health, Inc. (LHDX) Company Bio


Lucira Health, Inc. produces and distributes medical equipment. The Company offers disposable test kits to detect DNA and RNA of infectious diseases. Lucira Health markets its products in the United States.


LHDX Latest News Stream


Event/Time News Detail
Loading, please wait...

LHDX Latest Social Stream


Loading social stream, please wait...

View Full LHDX Social Stream

Latest LHDX News From Around the Web

Below are the latest news stories about Lucira Health Inc that investors may wish to consider to help them evaluate LHDX as an investment opportunity.

Lucira Health Shares Fall After Announcing Debt Facility Of $80M

Lucira Health Inc (NASDAQ: LHDX) has entered into a debt facility of up to million with Hercules Capital and Silicon Valley Bank. Under the term loan, Lucira received the first tranche of $30 million at closing. The Company will receive the second tranche of $20 million upon achieving certain milestones between September 1, 2022, and March 31, 2023. The third tranche of $15 million will be available before June 15, 2023, also contingent on certain milestones, while the fourth tranche of $15 mill

Yahoo | February 8, 2022

Lucira Health Secures Debt Facility of Up to $80 Million from Hercules Capital and Silicon Valley Bank

EMERYVILLE, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that on February 4, 2022, it entered into a debt facility of up to $80 million with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules") and Silicon Valley Bank (NASDAQ: SIVB) ("SVB"). "This debt financing will provide Lucira l

Yahoo | February 8, 2022

The past year for Lucira Health (NASDAQ:LHDX) investors has not been profitable

As every investor would know, you don't hit a homerun every time you swing. But serious investors should think long and...

Yahoo | February 7, 2022

Lucira™ Health Commits 2 Million At-Home Molecular COVID-19 Test Kits on Amazon

Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology company focusing on the development and commercialization of transformative and innovative infectious disease test kits, announced more than two million Lucira™ Check-It COVID-19 tests, a rapid at-home test with PCR-quality accuracy, are available on Amazon.com. Lucira's tests are available with 1-2 day Prime delivery nationwide.

Yahoo | February 3, 2022

Roche to offer 'tens of millions' of at-home Covid tests by end of month

The rollout comes amid long lines at testing sites and President Joe Biden's promise to increase the number of tests available.

Yahoo | January 11, 2022

Read More 'LHDX' Stories Here

LHDX Price Returns

1-mo 0.54%
3-mo -48.62%
6-mo -78.40%
1-year -70.29%
3-year N/A
5-year N/A
YTD -78.40%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4066 seconds.